• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Twitter
  • YouTube
CDE Almería – Centro de Documentación Europea – Universidad de Almería

CDE Almería - Centro de Documentación Europea - Universidad de Almería

Centro de Documentación Europea de la Universidad de Almería

  • HOME
  • WHAT´S ON
    • EU BULLETINS
    • EU NEWS
    • Activities
    • EU Calls and Awards
    • Radio Program «Europe with You»
  • DOCUMENTATION
    • Bibliographic Collection
      • Almería EDC Digital Collection
      • UNIVERSITY OF ALMERIA LIBRARY
    • Documentation by topic
    • EU Media Collection
      • Web Space
      • MEDIATHEQUE REPOSITORY
  • Europe on the net
    • Institutions
    • EU Representation in Spain
    • European information network of Andalusia
    • EU official journal
  • ABOUT US
    • Presentation
    • People
    • Contact
  • Spanish
  • English

New future-proof EU pharmaceutical policy

Inicio » EU News » New future-proof EU pharmaceutical policy

29 de November de 2021

Pharmaceutical technician in sterile environment working in the production of pills in the pharmacy factory

Affordable medicines, preventing shortages and a climate-neutral industry – Parliament presses for a new EU pharmaceutical policy.

During the plenary session in November 2021, the European Parlimanet set out a series of recommendations for the update of the EU’s pharmaceutical legislation.

Faster access

In 2019, the European Medicines Agency (EMA) authorised 103 orphan drugs – which are drugs to treat rare medical conditions – but only half of them reached the market, with an average delay of two years. This is just one of the issues raised in a report about EU pharmaceutical policy. To solve this problem MEPs called for shorter approval times by national agencies and alignment with the European Medicines Agency to ensure rapid and equal access to medicines across the EU.

Read more about EU public health measures

Shortages of medicines

The Covid-19 crisis has highlighted shortages of medicines and medical equipment, putting patients at risk and national health systems under pressure. Parliament called on the European Commission to address the root causes of shortages and propose sustainable solutions including the timely entry into the market of generic and biosimilar medicines in order to ensure patients have access to safe and affordable drugs.

Find more about medicine shortages and Parliament’s solutions

Environmentally friendly pharmaceutical industry

Parliament also said the pharmaceutical industry should become environmentally friendly and product life cycles should be climate-neutral. The Parliament stressed the need to strengthen EU manufacturing and supply resilience and to increase transparency on prices and public funding for research and development.

MEPs recommend coordinated awareness campaigns on antimicrobial resistance; and developing adequate capacity for the sustainable production of active substances, raw materials and medicines in order to reduce dependence on external sources.

The report calls on the Commission to fully implement the Clinical Trials Regulation to facilitate the launch of large clinical trials carried out in a harmonised and coordinated manner at EU level.

More information:

European Parliamen

Publicaciones relacionadas:

Regulatory flexibility to ensure availability of veterinary medicines during COVID-19 Coronavirus Global Response: €7.4 billion raised for universal access to vaccines Statistics: COVID-19 evolution in the Western Pacific – May Statistics: COVID-19 evolution in Eastern Mediterranean – May Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines

“This is a space for debate. All comments, for or against publication, that are respectful and do not contain expressions that are discriminatory, defamatory or contrary to current legislation will be published”.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Publicaciones relacionadas

Regulatory flexibility to ensure availability of veterinary medicines during COVID-19 Coronavirus Global Response: €7.4 billion raised for universal access to vaccines Statistics: COVID-19 evolution in the Western Pacific – May Statistics: COVID-19 evolution in Eastern Mediterranean – May Global regulators discuss data requirements for phase 3 trials of COVID-19 vaccines

Footer

Logotipo en negativo del Centro de Documentación Europea de Almería
  • CDE Almería
  • Edificio Parque Científico-Tecnológico (Pita)
  • Planta: 1ª, Despacho: 2904120.
  • Ctra. Sacramento s/n. Almería (Spain)
  • Teléfono: (+34) 950 015266

HOME
NEWS
DOCUMENTATION
EUROPE ON THE NET
ABOUT US

  • LEGAL NOTICE
  • PRIVACY POLICY
  • COOKIE POLICY
  • ACCESSIBILITY
  • SITEMAP

Copyright © 2023 CDE Almería · Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

<p>El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. ajustes</p>

Politica de privacidad

El Centro de Documentación Europea de la Universidad de Almería utiliza cookies propias y de terceros para facilitar al usuario la navegación en su página Web y el acceso a los distintos contenidos alojados en la misma. Asimismo, se utilizan cookies analíticas de terceros para medir la interacción de los usuarios con el sitio Web. Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. <a href="/politica-de-cookies" rel="noopener" target="_blank">Más información</a>

Cookies estrictamente necesarias

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Básicamente la web no funcionara bien si no las activas.

Estas cookies son:

  • Comprobación de inicio de sesión.
  • Cookies de seguridad.
  • Aceptación/rechazo previo de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

Cookies de terceros

Esta web utiliza Google Analytics, Google Tag Manager y Yandex Metrika para recopilar información anónima tal como el número de visitantes del sitio, o las páginas más populares.

Dejar estas cookies activas nos permite mejorar nuestra web.

¡Por favor, activa primero las cookies estrictamente necesarias para que podamos guardar tus preferencias!

Política de cookies

Pinche el siguiente enlace si desea información sobre el uso de cookies y como deshabilitarlas. Más información